Insiders · Profile

Levine Mark S.

Chief Legal Officer at Immunovant · SVP,General Counsel & Sec. at Minerva Neurosciences. Filing since 4 Jan 2017. CIK 0001617236

Company
Date
Role
Action
Shares
Amount
Of holding
20 Nov 2024
Chief Legal Officer
Sold at will
3,650
$92.89K
1.1%
23 Oct 2024
Chief Legal Officer
Sold at will
4,361
$128.78K
1.3%
16 Oct 2024
Chief Legal Officer
Sold at will
2,860
$82.34K
0.9%
21 Aug 2024
Chief Legal Officer
Sold at will
3,295
$104.98K
1.0%
24 Jul 2024
Chief Legal Officer
Sold at will
4,015
$111.46K
1.2%
17 Jul 2024
Chief Legal Officer
Sold at will
2,505
$74.38K
0.7%
22 May 2024
Chief Legal Officer
Sold at will
3,242
$96.13K
0.9%
24 Apr 2024
Chief Legal Officer
Sold at will
3,963
$114.53K
1.1%
17 Apr 2024
Chief Legal Officer
Sold at will
9,827
$285.55K
2.8%
22 Feb 2024
Chief Legal Officer
Sold at will
2,134
$77.14K
0.7%
26 Jan 2024
Chief Legal Officer
Sold at will
3,027
$114.78K
1.0%
22 Nov 2023
Chief Legal Officer
Sold at will
3,252
$106.60K
1.0%
25 Oct 2023
Chief Legal Officer
Sold at will
4,107
$142.35K
1.3%
24 Aug 2023
Chief Legal Officer
Sold at will
12,286
$249.41K
3.8%
26 Jul 2023
Chief Legal Officer
Sold at will
3,917
$84.72K
1.2%
25 Apr 2023
Chief Legal Officer
Sold at will
2,633
$42.89K
0.8%
26 Jan 2023
Chief Legal Officer
Sold, plan not stated
10,156
$187.99K
4.0%
1 Jun 2017
SVP,General Counsel & Sec.
Sold, plan not stated
17,500
$192.50K
100%
4 Jan 2017
SVP,General Counsel & Sec.
Sold, plan not stated
17,500
$210.00K
100%
19 decisions on file.